<span style="color: #222222;">The US Food and Drug Administration has approved a corona virus diagnostic test that can be conducted entirely at the point-of-care and can deliver results in 45 minutes.</span><br />'' <span style="color: #222222;"><br />'' US Health and Human Services Secretary, &nbsp;Alex Azar said the test &nbsp;will be able to provide &nbsp;results within hours, rather than days like the existing tests. He said the company &nbsp;will &nbsp;roll it out by March 30.</span><br />'' <span style="color: #222222;"><br />'' Developed by California-based company Cephid, the test would help fast identification of infected people and quickly start treating them and their quarantine.</span><br />'' <span style="color: #222222;"><br />'' Point-of-care testing means &nbsp;results are delivered to patients in the patient care settings, like hospitals, urgent care centres and emergency rooms, instead of samples being sent to a laboratory.</span><br />'' &nbsp;
News On AIR | March 22, 2020 9:00 AM
US FDA approves first rapid 'point-of-care' test for coronavirus